Dexcom (DXCM) Accounts Payables (2011 - 2012)
Dexcom's (DXCM) quarterly Accounts Payables came in at $3.9 million in Q4 2012, up 39.29% year-over-year from $2.8 million in Q1 2012, and up 2.74% quarter-over-quarter from $3.8 million in Q3 2012.
Powered by 
Analysis
Dexcom (DXCM) Accounts Payables (2011 - 2012) Analysis & Trends
Dexcom (DXCM) has reported Accounts Payables for 2 consecutive years, with $3.9 million the latest figure, recorded in Q4 2012.
- On a quarterly basis, Accounts Payables rose 39.29% year-over-year to $3.9 million in Q4 2012; TTM through Dec 2012 was $3.9 million, a 39.29% increase from a year earlier, with the FY2012 full-year figure at $3.9 million, up 39.29% from the prior year.
- Accounts Payables was $3.9 million for Q4 2012 at Dexcom, up from $3.8 million in the prior quarter.
- Over five years, Accounts Payables peaked at $3.9 million in Q4 2012 and troughed at $2.0 million in Q2 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 277.20 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 2.70 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.66 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 1.23 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 210.50 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 968.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn | 352.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | 3.90 Mn |
| Sep 30, 2012 | 3.80 Mn |
| Jun 30, 2012 | 2.02 Mn |
| Dec 31, 2011 | 2.80 Mn |